Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2004-07-23
2009-11-10
Nickol, Gary B (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S178100
Reexamination Certificate
active
07615221
ABSTRACT:
The invention features compositions and methods for treating or alleviating a symptom of cancer. The compositions and methods of the invention direct supra-lethal doses of radiation, called Hot-Spots, to virtually all cancer cell types.
REFERENCES:
patent: 4892817 (1990-01-01), Pawlak
patent: 5816259 (1998-10-01), Rose
patent: 6080383 (2000-06-01), Rose
patent: 6468503 (2002-10-01), Rose
patent: 2005/0058652 (2005-03-01), Mayers et al.
patent: WO 9830247 (1998-07-01), None
patent: WO 02/087497 (2002-11-01), None
patent: WO 2004/072238 (2004-08-01), None
Eschenburg et al., J Biol Chem. Feb. 4, 2005;280(5):3757-63. Epub Nov. 5, 2004.
Samland et al., Biochemistry. Feb. 13, 2001;40(6):1550-9.
Molina-Lopez et al., Peptides. Dec. 2006;27(12):3115-21. Epub Oct. 9, 2006.
Zemell et al., J Biol Chem. Jul. 10, 1975;250(13):4959-64, Abstract Only.
Fanjul-Bolado et al., Analytica chimica acta 2005; 534(2):231-238, Abstract Only.
Sigma Catalog, B1026, CAS No. 102185-33-1, MDL No. MFCD00036757—5-bromo-4-cholor-3-indolyl phosphate disodium salt.
Aboud-Pirak et al. PNAS USA. May 1989. 86:3778-3781.
Suwa et al., Anticancer Res Sep.-Oct. 1999;19(5B):4161-5, abstract only.
Krauss et al., (Breast Dis. 2000;11:113-24, abstract only.
Mehvar, (J Control Release, Oct. 3, 2000;69(1):1-25.
Rose. J Theor Biol. 1998;195:111-128.
Baumann et al., “Targeting the epidermal growth factcr receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results”,Radiother. Oncol., 72(3):257-266 (2004).
Milas et al., “Epidermal growth factor receptor and tumor response to radiation:In Vivopreclinical studies”,Int. J. Radiation Oncol. Biol. Phys., 58(3)966-971 (2004).
Panwar et al., “Radiolabeling and biological evaluation of DOTA-Ph-A1 derivative conjugated to anti-EGFR antibody ior efg/r3 for targeted tumor imaging and therapy”,Cancer Biol. Ther., 4(8):854-860 (2005).
Raben et al., “The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer”,Clin. Cancer Res., 11:795-805 (2005).
Chin Hsiao-Ling
Lee David
Mayers George L.
Kozakiewicz Cynthia
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Nickol Gary B
Oncologic, Inc.
Woodward Cherie M
LandOfFree
Compositions and methods for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4133021